Haemodynamic effects of levosimendan in advanced but stable chronic heart failure

Clicks: 347
ID: 272406
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #6 of 9 articles by views in ESC heart failure

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Levosimendan was associated with improved haemodynamics in patients with stable chronic HF, but we could not identify any predictors of the magnitude of haemodynamic response.
Reference Key
e2018eschaemodynamic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Najjar E;Stålhberg M;Hage C;Ottenblad E;Manouras A;Haugen Löfman I;Lund LH;;
Journal ESC heart failure
Year 2018
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/29469177
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't female male middle aged Prospective Studies Randomized Controlled Trial follow-up studies dose-response relationship drug intravenous infusions hemodynamics / drug effects heart failure / drug therapy* cardiotonic agents / administration & dosage heart failure / physiopathology pmid:29469177 pmc5933961 doi:10.1002/ehf2.12272 emil najjar marcus stålhberg lars h lund hemodynamics / ethics* simendan / administration & dosage*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.